E-Learning

Lower interest rates increased appetite for dealmaking, underwriting and other corporate banking activities while the wealth management business, a capital-light and fee-based business, has also boomed recently, powered by a rise in the number of high net-worth individuals and increasing investments. But heightened geopolitical uncertainty and an ongoing tariff threat from the U.S. government could potentially hurt the Canadian economy, slow loan growth and pressure consumers with mortgages.

Egg and butter company Vital Farms (NASDAQ:VITL) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 22.2% year on year to $166 million. The company’s full-year revenue guidance of $740 million at the midpoint came in 4.7% above analysts’ estimates. Its GAAP profit of $0.23 per share was 40% above analysts’ consensus estimates.

Local broadcasting and digital media company Nexstar (NASDAQ:NXST) reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 14.1% year on year to $1.49 billion. Its GAAP profit of $7.56 per share was 6.2% below analysts’ consensus estimates.

Fast-food pizza chain Papa John’s (NASDAQ:PZZA) announced better-than-expected revenue in Q4 CY2024, but sales fell by 7.1% year on year to $530.8 million. Its non-GAAP profit of $0.63 per share was 27.1% above analysts’ consensus estimates.

Heating and cooling solutions company AAON (NASDAQ:AAON) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 2.9% year on year to $297.7 million. Its non-GAAP profit of $0.30 per share was 43.7% below analysts’ consensus estimates.

Casino, sports betting and entertainment operator PENN Entertainment (NASDAQ:PENN) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 19.6% year on year to $1.67 billion. Its non-GAAP loss of $0.44 per share was 17.6% below analysts’ consensus estimates.

Healthcare services company Sotera Health (NASDAQ:) met Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 6.5% year on year to $290.2 million. Its non-GAAP profit of $0.21 per share was in line with analysts’ consensus estimates.

Medication company Viatris (NASDAQ:VTRS) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 8.1% year on year to $3.53 billion. The company’s full-year revenue guidance of $13.75 billion at the midpoint came in 3.3% below analysts’ estimates. Its non-GAAP profit of $0.54 per share was 5.6% below analysts’ consensus estimates.

As the U.S. housing market continues to defy economic uncertainty, Westlake Corporation is benefiting from strong demand for building materials, even as its chemicals business struggles.

Eyewear retailer Warby Parker (NYSE:WRBY) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 17.8% year on year to $190.6 million. The company’s full-year revenue guidance of $885.5 million at the midpoint came in 1.5% above analysts’ estimates. Its GAAP loss of $0.06 per share was $0.01 below analysts’ consensus estimates.